Sensory neurons that respond to temperature, touch and pain have ways of adapting to repeated stimuli that can change how a ...

Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the FDA. It is the first opioid-free painkiller of its kind in more than 20 ...

Results of a database review revealed duloxetine, pregabalin, and milnacipran as the only effective pharmacological therapies for managing pain in fibromyalgia.

Dr. Steven P. Cohen added hydrodissection — injecting fluid around severed nerves — to typical opioid use in treating ...

A new Mount Sinai study provides compelling evidence that exercise can significantly help the mental well-being of millions ...

Journavx works by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, which intercepts pain signals before they reach the brain. This approval marks the ...

Dr. Abhishek Reddy and Dr. Joe Fuhrman stop by Houston Life to discuss their innovative approach to pain management.

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...